Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jemperli
Pharma
GSK's Jemperli snags FDA nod in rectal cancer after data buzz
The accelerated approval makes Jemperli the first immunotherapy for patients with stage 2 and 3 locally advanced rectal cancer that is MSI-H/dMMR.
Angus Liu
Oct 19, 2026 1:24pm
Merck touts Keytruda front-line win in endometrial cancer subtype
Jul 15, 2026 3:33pm
GSK to seek FDA approval for Jemperli in high-profile cancer use
Jul 13, 2026 10:50am
GSK’s Tesaro can’t trim AnaptysBio's Jemperli royalties: judge
Apr 28, 2026 8:41am
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli
Jan 20, 2026 2:26pm
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am